CARL GORDON

Profile

First Name

: CARL

Middle Name

:

Last Name

: GORDON

Related Companies
Titles
Company Name
Related People
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2025-11-25 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2025-06-16 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2025-09-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-08-22 
D/A
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-11-01 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-14 
D
PHARMACEUTICALS 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2024-11-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-10-17 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-25 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-08 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-14 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-12-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-25 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-08-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-01-23 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-01-26 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-16 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-05-13 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-09 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-28 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-14 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-17 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-05 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-14 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-22 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-11-04 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-24 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-03-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-25 
D
 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-21 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-02 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-10-18 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-14 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-17 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-14 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2017-12-22 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2017-11-20 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-04-24 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-12-02 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-04-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-04-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-01-13 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-12-16 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-27 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-17 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-04-10 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-08 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-08-14 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-07-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-07 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-30 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-08 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2012-09-14 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-09-14 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-24 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-08 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2012-04-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-16 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-24 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-11-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-11-07 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-20 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-05-06 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-05-06 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-01-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-09-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-09-02 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2010-08-11 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-10 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-20 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-03 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-24 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2009-07-02 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-05-19